Short interest in Hansa Biopharma AB (OTC:HNSBF) decreased during the last reporting period, falling from 542.35K to 541.04K. This put -% of the company's publicly available shares short.

Short interest for Hansa Biopharma gives investors a sense of the degree to which investors are betting on the decline of Hansa Biopharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 33.00 shares traded per day, it would take 999.99 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.